stars 1 stars 2 stars 3

Vetruus Ltd was set up in the summer of 2011 by a small group of dedicated industry professionals with over 50 years of combined experience in the veterinary pharmaceutical industry. Vetruus works in partnership with several pharmaceutical manufacturers to bring to the UK market new, innovative and scientifically proven products, with an emphasis on dermatologicals. We are working closely with the Italian company ICF, who for over 20 years have been European leaders in veterinary dermatologicals. Vetruus is proud to be the UK and Republic of Ireland partner and exclusive distributor for a wide range of scientifically proven products such as Otodine, Clorexyderm Oto, Otoprof and Zincoseb Shampoo. As well as pharmaceutical products, we also have a great range of non-pharmaceutical products. Innovative products like Dog-Ends, Hound Surround dog collars, Ear Wicks and our specialist supplements Onychotin, Melacutin and Zinacutin, are already being talked about as offering solutions for problems seen every day in veterinary practice. Please visit our product pages for detailed information on the full Vetruus range.

Vetruus Limited Questions

The Vetruus Limited annual revenue was $2 million in 2026.

Philip Gurney is the Managing Director of Vetruus Limited.

4 people are employed at Vetruus Limited.

The NAICS codes for Vetruus Limited are [54, 541, 541940, 54194, 5419].

The SIC codes for Vetruus Limited are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users